Hormonal and subjective responses to intravenous m- chlorophenylpiperazine in women with seasonal affective disorder

Archives of General Psychiatry

Volumn 55, Issue 3, 1998, Pages 244-249

  Levitan, Robert D ^a,d   Kaplan, Allan S ^b   Brown, Gregory M ^a   Vaccarino, Franco J ^a   Kennedy, Sidney H ^a   Levitt, Anthony J ^a   Joffe, Russell T ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; HYDROCORTISONE; PROLACTIN; PLACEBO;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLICULAR PHASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WINTER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SCREENING; PRIORITY JOURNAL;

ADULT; AFFECT; DOUBLE-BLIND METHOD; FEMALE; FOLLICULAR PHASE; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PIPERAZINES; PLACEBOS; PROLACTIN; SEASONAL AFFECTIVE DISORDER; SEROTONIN AGONISTS;

EID: 0032498828     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.3.244     Document Type: Article

References (60)

1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41:72-80.
2. Lewy AJ, Sack RL, Singer CM. Assessment and treatment of chronobiologic disorders using plasma melatonin levels and bright light exposure: the clock-gate model and the phase-response curve. Psychopharmacol Bull. 1984;20:561-565.
3. Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science. 1987;235:352-354.
4. Terman MF, Quitkin JS, Terman JS, Stewart J, McGrath P. The timing of phototherapy. Psychopharmacol Bull. 1987;23:354-357.
5. Czeisler CA, Kronauer RE, Mooney JJ, Anderson JL, Allan JS. Biological rhythm disorders, depression, and phototherapy: a new hypothesis. Psychiatr Clin North Am. 1987;10:687-709.
6. Wirz-Justice A, Graw P, Krauchi K, Gisin B, Jochum A, Arendt J, Fisch HU, Buddeberg C, Poldinger W. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psychiatry. 1993;50:929-937.
7. Carlsson A, Svennerhom L, Winblad B. Seasonal and circadian monoamine variations in human brain examined post mortem. Acta Psychiatr Scand Suppl. 1980;280:75-83.
8. Brewerton TD, Berrettini WH, Nurnberger JI Jr, Linnoila M. Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls. Psychiatry Res. 1988;23:257-265.
9. Brewerton TD. Seasonal variation of serotonin function in humans: research and clinical implications. Ann Clin Psychiatry. 1989;1:153-164.
10. Lacoste V, Wirz-Justice A. Seasonal variation in normal subjects: an update of variables current in depression research. In: Rosenthal ME, Blehar MC, eds. Seasonal Affective Disorders and Phototherapy. New York, NY: Guilford Press; 1989:167-229.
11. Meltzer HY, Arora RC, Baber R,Tricou BJ. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry. 1981;38:1322-1326.
12. Van Praag HM. Management of depression with serotonin precursors. Biol Psychiatry. 1981;16:290-310.
13. Moller SE, Kirk L, Honore P. Tryptophan tolerance and metabolism in major depression. Psychopharmacology. 1982;76:79-83.
14. Heninger GR, Charney DS, Sternberg DE. Serotonergic function in depression. Arch Gen Psychiatry. 1984;41:398-402.
15. Briley M. Imipramine binding: its relationship with serotonin. In: Green AR, ed. Neuropharmacology of Serotonin. Oxford, England: Oxford University Press; 1985:50-78.
16. Young SN, Smith SE, Pihl R, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 1985;87:173-177.
17. Koyama T, Meltzer HY. A biochemical and neuroendocrine study of the serotonergic system in depression. In: Hippius H, Klerman GL, Matussek N, eds. New Results in Depression Research. Berlin, Germany: Springer-Verlag; 1986:169-188.
18. Cowen PJ, Charig EM. Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry. 1987;44:958-966.
19. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of anti-depressant action. Arch Gen Psychiatry. 1990;47:411-418.
20. Price LH, Charney DS, Delgado PL, Heninger GR. Serotonin function and depression. Am J Psychiatry. 1991;148:1515-1525.
21. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN. Mood-lowering effect of tryptophan depletion. Arch Gen Psychiatry. 1994;51:687-697.
22. Goudie A, Thornton E, Wheeler T. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. J Pharm Pharmacol. 1976;28:318-320.
23. Blundell JE. Is there a role for serotonin in feeding? Int J Obesity. 1977;1:15-42.
24. Wurtman JJ, Wurtman RJ. Drugs that enhance central serotonergic transmission diminish selective carbohydrate consumption by rats. Life Sci. 1979;24:895-904.
25. Blundell J. Serotonin and appetite. Neuropharmacology. 1984;23:1537-1551.
26. Leibowitz S, Shor-Posner G. Brain serotonin and eating behavior. Appetite. 1986;7:1-14.
27. Jouvet M. Biogenic amines and the states of sleep. Science. 1969;163:32-41.
28. Griffiths WJ, Lester BK, Coulter JD. Tryptophan and sleep in young adults. Psychophysiology. 1972;9:345-350.
29. Rosenthal NE, Genhart FM, Jacobsen RG, Skwerer RG, Wehr TA. Disturbances of appetite and weight regulation in seasonal affective disorder. Ann N Y Acad Sci. 1987;499:216-230.
30. Krauchi K, Wirz-Justice A, Gnaw P. The relationship of affective state to dietary preference. J Affective Disord. 1990;20:43-53.
31. Jacobsen FM, Dreizzen A, Rosenthal ME, Wehr TA. Diurnal variation in seasonal affective disorder. Presented at the 140th annual meeting of the American Psychiatric Association, Chicago, III, May 1987.
32. O'Rourke D, Wurtman JJ, Wurtman RJ, Chebli R, Gleason R. Treatment of seasonal depression with D-fenfluramine. J Clin Psychiatry. 1989;40:343-347.
33. McGrath RE, Buckwald B, Resnick EV. The effect of L-tryptophan on seasonal affective disorder. J Clin Psychiatry. 1990;51:162-163.
34. Lam RW, German CP, Michalon M, Steiner M, Levitt AJ, Corral MR, Watson GD, Morehouse RL, Tam W, Joffe RT. A multi-center, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry. 1995;12:1765-1770.
35. Ruhrmann S, Kasper S, Hawellek B, Martinez B, Hoflich G, Nickeisen T, Moller H-J. Fluoxetine vs light therapy in the treatment of SAD. Biol Psychiatry. 1993;33:83A. Abstract.
36. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53:41-44.
37. Rosenthal NE, Genhart M, Caballero B, Jacobsen FM, Skwerer RG, Coursey RD, Rogers S, Spring BJ. Psychobiological effects of carbohydrate- and protein-rich meals in patients with seasonal affective disorder and normal controls. Biol Psychiatry. 1989;25:1029-1040.
38. Fernstrom JD, Wurtman RJ. Brain serotonin content: increase following ingestion of a carbohydrate diet. Science. 1971;174:1023-1025.
39. Wurtman RJ. Nutrients that modify brain function. Sci Am. 1982;246:42-51.
40. Jacobsen FM, Sack DA, Wehr TA, Rogers S, Rosenthal NE. Neuroendocrtne responses to 5-hydroxytryptamine in seasonal affective disorder. Arch Gen Psychiatry. 1987;44:1086-1091.
41. Coiro V, Volpi R, Marchesi C, De Ferri A, Davolli C, Caffarra P, Rossi G, Caffarri G, Davolio M, Chiodera P. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder. Psychoneuroendocrinology. 1993;18:551-556.
42. Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to mCPP in patients with seasonal affective disorder and controls. Biol Psychiatry. 1993;33:496-504.
43. Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren DA, Moul DE, Ozaki N, Snelbaker AJ, Rosenthal NE. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder. Arch Gen Psychiatry. 1997;54:617.
44. Yatham LN, Lam RW, Zis AP. Growth hormone responses to sumatriptan challenge in seasonal affective disorder. Biol Psychiatry. 1996;39:617. Abstract.
45. Mueller EA, Murphy DL, Sunderland T. Neuroendocrine effects of m-chlorophenylpiperazine, a serotonergic agonist, in humans. J Clin Endocrinol Metab. 1985;61:1179-1184.
46. Hamik A, Petrouka SJ. 1-(m-chlorophenylpiperazine) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry. 1989;25:569-575.
47. Hoyer D. Functional correlates of serotonin 5-HT-1 recognition sites. J Receptor Res. 1988;8:59-81.
48. Mueller EA, Murphy DL, Sunderland T. Further studies of the putative serotonin agonist m-chlorophenylpiperazine. Psychopharmacology. 1986;89:388-391.
49. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM. Comparative anxiogenic, neuroendocrine, and other physiological effects of m-chlorophenylpiperazine given intravenously to healthy volunteers. Psychopharmacology. 1989;98:275-282.
50. Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose response study. Psychopharmacology. 1990;100:339-344.
51. Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 1992;106:388-390.
52. Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry. 1997;54:521-527.
53. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
54. Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-III. New York, NY: New York State Psychiatric Institute, Biometrics Research Division; 1982.
55. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;6:278-296.
56. Williams JBW, Link MJ, Rosenthal NE, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale. Seasonal Affective Disorders Version (SIGH-SAD). New York, NY: New York State Psychiatric Institute; 1988.
57. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. New York, NY: New York State Psychiatric Institute, Biometrics Research Division; 1977.
58. Beck AT, Ward CH, Mendetson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
59. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. Serotonin function in obsessive-compulsive disorder. Arch Gen Psychiatry. 1987;45:177-185.
60. Garcia-Borreguero D, Jacobsen FM, Murphy DL. Joseph-Vanderpool JR, Chiara A, Rosenthal NE. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls. Biol Psychiatry. 1995;37:740-749.